Column Group’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Buy |
1,328,613
+1,162,536
| +700% | +$9.3M | 16.17% | 3 |
|
|
2025
Q1 | $1.62M | Hold |
166,077
| – | – | 3.67% | 4 |
|
|
2024
Q4 | $2.1M | Sell |
166,077
-169,001
| -50% | -$2.14M | 3.77% | 4 |
|
|
2024
Q3 | $5.39M | Hold |
335,078
| – | – | 7.74% | 4 |
|
|
2024
Q2 | $8.18M | Hold |
335,078
| – | – | 11.47% | 4 |
|
|
2024
Q1 | $24.1M | Hold |
335,078
| – | – | 14.99% | 4 |
|
|
2023
Q4 | $66.6M | Hold |
335,078
| – | – | 44% | 1 |
|
|
2023
Q3 | $44.6M | Hold |
335,078
| – | – | 29.58% | 1 |
|
|
2023
Q2 | $50.1M | Hold |
335,078
| – | – | 19.45% | 3 |
|
|
2023
Q1 | $49.2M | Hold |
335,078
| – | – | 17.79% | 3 |
|
|
2022
Q4 | $53.1M | Buy |
335,078
+21
| +0% | +$3.33K | 17.67% | 3 |
|
|
2022
Q3 | $64.5M | Hold |
335,057
| – | – | 14.27% | 3 |
|
|
2022
Q2 | $48.9M | Buy |
335,057
+159,806
| +91% | +$23.3M | 10.41% | 4 |
|
|
2022
Q1 | $30.8M | Hold |
175,251
| – | – | 5.72% | 4 |
|
|
2021
Q4 | $51.5M | Hold |
175,251
| – | – | 7% | 6 |
|
|
2021
Q3 | $43.5M | Sell |
175,251
-310,459
| -64% | -$77.1M | 4.95% | 7 |
|
|
2021
Q2 | $124M | Hold |
485,710
| – | – | 17.48% | 2 |
|
|
2021
Q1 | $86.3M | Hold |
485,710
| – | – | 8.26% | 5 |
|
|
2020
Q4 | $76.7M | Buy |
+485,710
| New | +$76.7M | 6.96% | 5 |
|